PPA
CCCC icon

Parametric Portfolio Associates’s C4 Therapeutics CCCC Stock Holding History

Parametric Portfolio Associates’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$677K Buy
27,888
+273
+1% +$6.63K ﹤0.01% 2950
2021
Q4 		$889K Buy
27,615
+673
+2% +$26.6K ﹤0.01% 2830
2021
Q3 		$1.2M Buy
26,942
+1,297
+5% +$55.5K ﹤0.01% 2715
2021
Q2 		$970K Buy
25,645
+3,525
+16% +$126K ﹤0.01% 2785
2021
Q1 		$818K Buy
22,120
+7,916
+56% +$315K ﹤0.01% 3257
2020
Q4 		$471K Buy
+14,204
New +$412K ﹤0.01% 3412

Other funds holding CCCC

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return